Design and development of ciclopirox topical nanoemulsion gel for the treatment of subungual onychomycosis

Indian Journal of Pharmaceutical Education and Research

Volumn 46, Issue 4, 2012, Pages 303-311

  Kumar, Sushil ^a   Talegaonkar, Sushama ^a   Negi, Lalit M ^a   Khan, Zeenat I ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Fluorescent microscopy thermodynamics stability; Nanoemulsion; Onychomycosis; Permeation

Indexed keywords

CARBOMER; CICLOPIROXOLAMINE; MACROGOL 400; OLEIC ACID; POLYSORBATE 80;

ANIMAL TISSUE; ARTICLE; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG STABILITY; EX VIVO STUDY; GEL; IN VITRO STUDY; NANOEMULSION; NONHUMAN; ONYCHOMYCOSIS; PARTICLE SIZE; RAT; SKIN PERMEABILITY; THERMODYNAMICS; ZETA POTENTIAL;

EID: 84873355847     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Murdan S. Istt meeting on topical drug delivery to the nail. Expert Opin Drug Delv. 2007; 4:453-5
2. Piraccini BB, lorizzo M, Antonucci A, Tosti A.Treatmentof nail disorders. Therapy, 2004; 1,159-67
3. Zaias N. Clinical manifestations of onychomycosis. Clin. Exp. Dermatol. 1992;17:6-7
4. Kara S, Nunley LC. Current Management of Onychomycosis. The J. of Hand Surgery. 2008.; 33:1211-4.
5. Jeffrey MR. Treatment of onychomycosis in the diabetic patient population. J Diabet. Comp. 2003; 17:98-104.
6. Baran R, Hay RJ, Garduno JL.review of antifungal therapy and the severity index for assessing onychomycosis.J.Dermatol. Treat. 2008; 19:72-8
7. Niewerth M, Kunze D, Seibold M, et al. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother. 2003; 47:1805-17
8. Sakeena MHF, Muthanna FA, Ghassan ZA, et al. Formulation and in vitro Evaluation of Ketoprofen in Palm Oil Esters Nanoemulsion for Topical Delivery. J. Oleo Sci. 2010; 59:223-8
9. Solanki AB, Parikh RJ, Parikh HR. Formulation and Optimization of Piroxicam Proniosomes by 3-Factor, 3-Level Box-Behnken Design. AAPS PharmSciTech. 2007; 8:5-7.
10. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, AN M. Development and bioavailability assessment of ramipril Nanoemulsion formulation. Eur J Pharm Biopharm. 2007; 66:227-43
11. Sakkinen M, Seppala U, Heinanen R, Marvola M. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules. Eur. J. Pharm. Biopharm. 2002; 54:33-40
12. Puranjoti P, Patil RT, Seth PD et al. Design and development of transdermal microemulsion for poorly water soluble antifungal agents. J. App. Res. Clin. Exp. Ther. 2002; 2:231-7
13. Djordjevic L, Primorac M, Stupar M, Krajisnik D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilicdrug. Int.J. Pharm. 2004; 271:11-19